Company registration number 07125879 (England and Wales)
LEVITY CROPSCIENCE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
PAGES FOR FILING WITH REGISTRAR
LEVITY CROPSCIENCE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
LEVITY CROPSCIENCE LIMITED
BALANCE SHEET
AS AT 31 JULY 2025
31 July 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
1,517,113
1,403,625
Current assets
Stocks
92,860
90,711
Debtors
5
518,097
296,706
Cash at bank and in hand
92,105
129,686
703,062
517,103
Creditors: amounts falling due within one year
6
(282,989)
(160,197)
Net current assets
420,073
356,906
Total assets less current liabilities
1,937,186
1,760,531
Creditors: amounts falling due after more than one year
7
(253,008)
(312,435)
Provisions for liabilities
(137,540)
(90,344)
Net assets
1,546,638
1,357,752
Capital and reserves
Called up share capital
8
130
130
Share premium account
95,970
95,970
Profit and loss reserves
1,450,538
1,261,652
Total equity
1,546,638
1,357,752

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

LEVITY CROPSCIENCE LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 JULY 2025
31 July 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 27 April 2026 and are signed on its behalf by:
Mr D J Marks
Director
Company Registration No. 07125879
LEVITY CROPSCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
- 3 -
1
Accounting policies
Company information

Levity CropScience Limited is a private company limited by shares incorporated in England and Wales. The registered office is Crowhall Farm, Newsham Hall Lane, Woodplumpton, Preston, PR4 0AS.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates. Turnover is recognised when goods are despatched.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Branding
5 years straight line
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

LEVITY CROPSCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 4 -

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
50 years straight line
Fixtures, fittings & equipment
5 years straight line
Computer equipment
3 years straight line
Motor vehicles
Straight line over the life of the lease

Freehold land and assets in the course of construction are not depreciated.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price. Financial assets classified as receivable within one year are not amortised.

Other financial assets

All of the company's assets are basic financial assets.

LEVITY CROPSCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 5 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors are initially recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. Trade creditors are recognised initially at transaction price.

Other financial liabilities

All of the company's financial liabilities are basic financial liabilities.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

LEVITY CROPSCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 6 -
1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Total
9
8
3
Intangible fixed assets
Branding
£
Cost
At 1 August 2024 and 31 July 2025
15,038
Amortisation and impairment
At 1 August 2024 and 31 July 2025
15,038
Carrying amount
At 31 July 2025
-
0
At 31 July 2024
-
0
LEVITY CROPSCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 7 -
4
Tangible fixed assets
Freehold land and buildings
Assets under construction
Fixtures, fittings & equipment
Computer equipment
Motor vehicles
Total
£
£
£
£
£
£
Cost
At 1 August 2024
346,078
1,026,088
20,310
10,585
70,166
1,473,227
Additions
-
0
100,925
28,044
499
-
0
129,468
At 31 July 2025
346,078
1,127,013
48,354
11,084
70,166
1,602,695
Depreciation and impairment
At 1 August 2024
-
0
-
0
7,387
8,620
53,595
69,602
Depreciation charged in the year
-
0
-
0
6,622
1,072
8,286
15,980
At 31 July 2025
-
0
-
0
14,009
9,692
61,881
85,582
Carrying amount
At 31 July 2025
346,078
1,127,013
34,345
1,392
8,285
1,517,113
At 31 July 2024
346,078
1,026,088
12,923
1,965
16,571
1,403,625
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
433,912
226,552
Other debtors
84,185
70,154
518,097
296,706
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
60,844
60,173
Trade creditors
165,133
48,048
Taxation and social security
21,444
15,104
Other creditors
35,568
36,872
282,989
160,197

Bank loans and overdrafts totalling £51,978 (2024: £52,297) have been secured by way of a fixed and floating charge over all current and future assets of the company.

LEVITY CROPSCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 8 -
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
253,008
312,435

Amounts within bank loans and overdrafts totalling £163,229 (2024: £213,790) have been secured by way of a fixed and floating charge over all current and future assets of the company.

8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 1p each
5,200
5,200
52
52
Ordinary A shares of 1p each
3,900
3,900
39
39
Ordinary B shares of 1p each
3,900
3,900
39
39
13,000
13,000
130
130
9
Related party transactions

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due to related parties
£
£
Key management personnel
5,333
5,333

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due from related parties
£
£
Key management personnel
47,307
17,771

The amounts due from key management personnel has been repaid in full within nine months of the period end.

LEVITY CROPSCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 9 -
10
Directors' transactions
Description
% Rate
Opening balance
Amounts advanced
Interest charged
Amounts repaid
Closing balance
£
£
£
£
£
Advances
2.25
17,771
65,917
1,619
(38,000)
47,307
17,771
65,917
1,619
(38,000)
47,307

The advances were unsecured and repayable on demand.

2025-07-312024-08-01falsefalsefalse27 April 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr D J MarksMrs A K WestonMr M A WestonMr M P Peters071258792024-08-012025-07-31071258792025-07-31071258792024-07-3107125879core:LandBuildingscore:OwnedOrFreeholdAssets2025-07-3107125879core:ConstructionInProgressAssetsUnderConstruction2025-07-3107125879core:FurnitureFittings2025-07-3107125879core:ComputerEquipment2025-07-3107125879core:MotorVehicles2025-07-3107125879core:LandBuildingscore:OwnedOrFreeholdAssets2024-07-3107125879core:ConstructionInProgressAssetsUnderConstruction2024-07-3107125879core:FurnitureFittings2024-07-3107125879core:ComputerEquipment2024-07-3107125879core:MotorVehicles2024-07-3107125879core:CurrentFinancialInstrumentscore:WithinOneYear2025-07-3107125879core:CurrentFinancialInstrumentscore:WithinOneYear2024-07-3107125879core:Non-currentFinancialInstrumentscore:AfterOneYear2025-07-3107125879core:Non-currentFinancialInstrumentscore:AfterOneYear2024-07-3107125879core:CurrentFinancialInstruments2025-07-3107125879core:CurrentFinancialInstruments2024-07-3107125879core:ShareCapital2025-07-3107125879core:ShareCapital2024-07-3107125879core:SharePremium2025-07-3107125879core:SharePremium2024-07-3107125879core:RetainedEarningsAccumulatedLosses2025-07-3107125879core:RetainedEarningsAccumulatedLosses2024-07-3107125879core:ShareCapitalOrdinaryShareClass12025-07-3107125879core:ShareCapitalOrdinaryShareClass12024-07-3107125879core:ShareCapitalOrdinaryShareClass22025-07-3107125879core:ShareCapitalOrdinaryShareClass22024-07-3107125879core:ShareCapitalOrdinaryShareClass32025-07-3107125879core:ShareCapitalOrdinaryShareClass32024-07-3107125879core:ShareCapitalOrdinaryShares2025-07-3107125879core:ShareCapitalOrdinaryShares2024-07-3107125879bus:Director12024-08-012025-07-3107125879core:IntangibleAssetsOtherThanGoodwill2024-08-012025-07-3107125879core:PatentsTrademarksLicencesConcessionsSimilar2024-08-012025-07-3107125879core:LandBuildingscore:OwnedOrFreeholdAssets2024-08-012025-07-3107125879core:FurnitureFittings2024-08-012025-07-3107125879core:ComputerEquipment2024-08-012025-07-3107125879core:MotorVehicles2024-08-012025-07-31071258792023-08-012024-07-3107125879core:PatentsTrademarksLicencesConcessionsSimilar2024-07-3107125879core:PatentsTrademarksLicencesConcessionsSimilar2025-07-3107125879core:PatentsTrademarksLicencesConcessionsSimilar2024-07-3107125879core:LandBuildingscore:OwnedOrFreeholdAssets2024-07-3107125879core:ConstructionInProgressAssetsUnderConstruction2024-07-3107125879core:FurnitureFittings2024-07-3107125879core:ComputerEquipment2024-07-3107125879core:MotorVehicles2024-07-31071258792024-07-3107125879core:ConstructionInProgressAssetsUnderConstruction2024-08-012025-07-3107125879core:Non-currentFinancialInstruments2025-07-3107125879core:Non-currentFinancialInstruments2024-07-3107125879bus:OrdinaryShareClass12024-08-012025-07-3107125879bus:OrdinaryShareClass22024-08-012025-07-3107125879bus:OrdinaryShareClass32024-08-012025-07-3107125879bus:OrdinaryShareClass12025-07-3107125879bus:OrdinaryShareClass12024-07-3107125879bus:OrdinaryShareClass22025-07-3107125879bus:OrdinaryShareClass22024-07-3107125879bus:OrdinaryShareClass32025-07-3107125879bus:OrdinaryShareClass32024-07-3107125879bus:AllOrdinaryShares2025-07-3107125879bus:AllOrdinaryShares2024-07-3107125879bus:PrivateLimitedCompanyLtd2024-08-012025-07-3107125879bus:SmallCompaniesRegimeForAccounts2024-08-012025-07-3107125879bus:FRS1022024-08-012025-07-3107125879bus:AuditExemptWithAccountantsReport2024-08-012025-07-3107125879bus:Director22024-08-012025-07-3107125879bus:Director32024-08-012025-07-3107125879bus:Director42024-08-012025-07-3107125879bus:FullAccounts2024-08-012025-07-31xbrli:purexbrli:sharesiso4217:GBP